Siran Biotech

Siran Biotech is a preclinical-stage biotechnology company specializing in the development of targeted RNA therapeutics. The company utilizes a proprietary delivery platform designed to overcome the challenges of extrahepatic siRNA delivery, enabling precise targeting of tissues beyond the liver. By combining advanced ligand chemistry with optimized nanoparticle formulations, Siran Biotech aims to treat a wide range of genetic and acquired diseases, including oncology and metabolic disorders. The company is headquartered in the Martinsried biotech hub near Munich and is a spin-off from academic research focused on intracellular delivery. Its technology platform, known as the Siran-Platform, focuses on the systemic administration of siRNA with high specificity for target cells.